ESOP/ESOS/ESPS

Date: July 30, 2026 Ref:- GHL/2026-27/EXCH/33 The General Manager The Manager Dept. of Corporate Services Listing Department BSE Limited, National Stock Exchange of India Limited P J Towers, Dalal Street, Exchange Plaza, C-1, Block G, Mumbai - 400 001 Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 Scrip Code: 543654 Symbol: MEDANTA Sub: Intimation of Grant of Options under GHL-Employee Long Term Share Based Incentive Plan 2024 (“GHL LTIP 2024 Plan”). Dear Sir(s), Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, (‘SEBI LODR Regulations’), we hereby inform you that the Nomination and Remuneration Committee of Global Health Limited (‘the Company’) in its meeting held today i.e. July 30, 2026, has approved the grant of 20,000 ESOPs to one employee under Part –A of GHL LTIP 2024 Plan i.e. GHL Employees Stock Option Scheme, 2024. Necessary disclosure in this regard as mandated under the Listing Regulations is attached herewith as Annexure. The meeting of the Nomination & Remuneration Committee commenced at 11:00 A.M. and concluded at 11:35 A.M. Kindly take the above on record. For Global Health Limited Rahul Ranjan Company Secretary & Compliance Officer M. No. A17035 Encl:a/a Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319 Annexure Disclosures as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 S. Particulars Information ESOS a) Global Health Limited The purpose of the GHL ESOS 2024 is to reward the (GHL) Employees Long Employees for their association, dedication and Term Share Based Incentive contribution to the goals of the Company. The Company Plan - 2024 (“GHL LTIP intends to use this ESOS to attract, retain and motivate 2024 Plan”) the key talents by way of rewarding their performance and motivate them to contribute to the overall corporate growth and profitability. The Company views ESOS as a long-term incentive tool that would enable the Employees not only to become co-owners, but also to create wealth out of such ownership in future. b) Whether the scheme is in Yes, GHL LTIP 2024 is in compliance with SEBI (Share terms of SEBI (SBEB) Based Employee Benefits and Sweat Equity) Regulations, 2021 (if Regulations, 2021. applicable) c) Total number of Shares The current grant is of 20,000 Stock options. covered by these options Note: Each Option will result into allotment of One (1) Equity Share of Rs. 2/- each. d) (Pricing formula or Exercise The current grant of Options under ESOS is issued for an cPrice Exercise Price of Rs. 1147/- each. e) Options vested Not applicable at this stage f) Time within which option The Vested Options shall be exercised within a maximum may be exercised period of 3 years from the date of vesting of last instalment of Options under GHL LTIP 2024 Plan. g) Options exercised Not applicable h) Money realized by exercise of options i) The total number of shares arising as a result of exercise of option j) Options lapsed; k) Variation of terms of options; l) Brief details of significant 1. One (1) employee is covered for the current grant. terms 2. Exercise Period: The vested Options are allowed for exercise on and from the date of vesting. The vested Options need to be exercised within a maximum period of 3 years from the date of vesting of last instalments of Options under ESOS. Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319 3. Vesting period: Options granted under current tranche would vest in accordance with the Vesting schedule and Vesting Conditions as outlined in the Grant letter, subject to maximum period of 5 years from the date of grant of such Options. m) Subsequent changes or Not applicable cancellation or exercise of such options; n) Diluted earnings per share Not applicable pursuant to issue of equity shares on exercise of options. Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319